Filter News
Area of Research
- (-) Clean Energy (29)
- (-) Supercomputing (34)
- Advanced Manufacturing (1)
- Biological Systems (1)
- Biology and Environment (25)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (1)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (9)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (24)
- Materials (66)
- Materials Characterization (1)
- Materials for Computing (11)
- Materials Under Extremes (1)
- National Security (38)
- Neutron Science (29)
- Nuclear Science and Technology (11)
News Type
News Topics
- (-) Advanced Reactors (5)
- (-) Biomedical (16)
- (-) Isotopes (2)
- (-) Materials Science (28)
- (-) National Security (11)
- 3-D Printing/Advanced Manufacturing (52)
- Artificial Intelligence (37)
- Big Data (15)
- Bioenergy (27)
- Biology (16)
- Biotechnology (5)
- Buildings (20)
- Chemical Sciences (14)
- Clean Water (4)
- Climate Change (27)
- Composites (7)
- Computer Science (81)
- Coronavirus (20)
- Critical Materials (4)
- Cybersecurity (14)
- Decarbonization (27)
- Energy Storage (48)
- Environment (43)
- Exascale Computing (21)
- Fossil Energy (2)
- Frontier (26)
- Fusion (1)
- Grid (24)
- High-Performance Computing (33)
- Machine Learning (15)
- Materials (30)
- Mathematics (2)
- Mercury (2)
- Microelectronics (1)
- Microscopy (12)
- Molten Salt (1)
- Nanotechnology (13)
- Net Zero (3)
- Neutron Science (18)
- Nuclear Energy (9)
- Partnerships (12)
- Physics (8)
- Polymers (6)
- Quantum Computing (15)
- Quantum Science (21)
- Renewable Energy (1)
- Security (9)
- Simulation (13)
- Software (1)
- Space Exploration (3)
- Summit (36)
- Sustainable Energy (39)
- Transformational Challenge Reactor (3)
- Transportation (38)
Media Contacts
ORNL and the Tennessee Valley Authority, or TVA, are joining forces to advance decarbonization technologies from discovery through deployment through a new memorandum of understanding, or MOU.
ORNL, TVA and TNECD were recognized by the Federal Laboratory Consortium for their impactful partnership that resulted in a record $2.3 billion investment by Ultium Cells, a General Motors and LG Energy Solution joint venture, to build a battery cell manufacturing plant in Spring Hill, Tennessee.
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
To explore the inner workings of severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2, researchers from ORNL developed a novel technique.
Neuromorphic devices — which emulate the decision-making processes of the human brain — show great promise for solving pressing scientific problems, but building physical systems to realize this potential presents researchers with a significant
ORNL and Tuskegee University have formed a partnership to develop new biodegradable materials for use in buildings, transportation and biomedical applications.
A team of collaborators from ORNL, Google Inc., Snowflake Inc. and Ververica GmbH has tested a computing concept that could help speed up real-time processing of data that stream on mobile and other electronic devices.
A team led by the U.S. Department of Energy’s Oak Ridge National Laboratory demonstrated the viability of a “quantum entanglement witness” capable of proving the presence of entanglement between magnetic particles, or spins, in a quantum material.
Four first-of-a-kind 3D-printed fuel assembly brackets, produced at the Department of Energy’s Manufacturing Demonstration Facility at Oak Ridge National Laboratory, have been installed and are now under routine operating
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.